Cas:52663-79-3 2,2′,3,3′,4,4′,5,6,6′-pcb manufacturer & supplier

We serve Chemical Name:2,2′,3,3′,4,4′,5,6,6′-pcb CAS:52663-79-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,2',3,3',4,4',5,6,6'-pcb

Chemical Name:2,2′,3,3′,4,4′,5,6,6′-pcb
CAS.NO:52663-79-3
Synonyms:2,2′,3,3′,4,4′,5,6,6′-pcb;2,2′,3,3′,4,4′,5,6,6′-Nonachlorobiphenyl;1,1′-Biphenyl, 2,2′,3,3′,4,4′,5,6,6′-nonachloro-;2,2′,3,3′,4,4′,5,6,6′-Nonachloro-1,1′-biphenyl;1,2,3,4,5-pentachloro-6-(2,3,4,6-tetrachlorophenyl)benzene
Molecular Formula:C12HCl9
Molecular Weight:464.213
HS Code:2903999090

Physical and Chemical Properties:
Melting point:193.25°C (estimate)
Boiling point:442.5±40.0 °C at 760 mmHg
Density:1.8±0.1 g/cm3
Index of Refraction:1.643
PSA:
Exact Mass:459.727509
LogP:7.84

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2,2′,3,3′,4,4′,5,6,6′-pcb chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,2,3,4,5-pentachloro-6-(2,3,4,6-tetrachlorophenyl)benzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2,3,4,5-pentachloro-6-(2,3,4,6-tetrachlorophenyl)benzene Use and application,2,2′,3,3′,4,4′,5,6,6′-pcb technical grade,usp/ep/jp grade.


Related News: This also includes experience for drug delivery systems, efficient teams, facilities, and production capabilities. dihydrido(η5-pentamethylcyclopentadienyl)(5-(diphenylphosphino)-25,26,27,28-tetra-n-propoxycalix[4]arene)rhodium(III) manufacturers Walmsley’s background in consumer health—and lack of prior experience in pharma—has reportedly been targeted by Elliott in the investment firm’s secret push for a new boss at GSK. L-Lysine, N2-[N-(N-glycyl-L-methionyl)glycyl]- suppliers In SLE, along with the pivotal TULIP phase III programme, anifrolumab continues to be evaluated in a long-term extension phase III trial.12 A phase II trial of anifrolumab in SLE using subcutaneous delivery has been completed. 7-[(E)-2-(6,7-difluoroquinolin-2-yl)vinyl]-5,11-dihydro[1]benzoxepino[3,4-b]pyridin-5-ol vendor & factory.